Fellow, Neonatology, Medical Center Hospital of Vermont (1989)
Resident PL3, Pediatrics, Medical Center Hospital of Vermont (1985)
Residency PL1, PL2, Pediatrics, Montreal Children's Hospital, Montreal, Quebec, Canada (1984)
Rotating Internship, McMaster University, Hamilton, Ontario, Canada (1982)
M.D., McMaster University, Hamilton, Ontario, Canada (1981)
B.A. Psychology, Carleton University, Ottawa, Ontario, Canada (1978)
Associate Professor of Pediatrics, University of Vermont College of Medicine, Burlington, VT (2005-present)
Medical Director, Neonatal Medical Follow-Up Program, The University of Vermont Children's Hospital, Burlington, VT
Attending Neonatologist, The University of Vermont Children's Hospital, Burlington, VT (1989-present)
Member, Children And Recovering Mothers Team (CHARM), Vermont Department of Health, Division of Alcohol and Drug Abuse Programs
American Academy of Pediatrics Special Achievement Award (2006)
Outstanding Collaboration Award, Kidsafe Collaborative of Chittenden County (2005)
Advances in Clinical Practice and Research, March of Dimes, Vermont Chapter (2002)
Director’s Award from Vermont Department of Health, Division of Alcohol and Drug Abuse (2002)
Meyer MC, Johnston AM, Crocker AM, Heil SH. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. J Addict Med. 2015 Mar-Apr;9(2):81-6.
Gaalema DE, Heil SH, Badger GJ, Metayer JS, Johnston AM. Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone. Drug Alcohol Depend. 2013 Nov 1: 133(1)266-9.
Meyer M, Benvenuto A, Howard D, Johnston A, Plante D, Metayer J, Mandell T. Development of a substance abuse program for opioid dependent non-urban pregnant women improves outcome. Journal of Addiction Medicine 2012;6:124-130.
Heil, S.H., Gaalema, D.E., Johnston, A.M., Sigmon, S.C., Badger, G.J., & Higgins, S.T. (in press). Infant pupillary response to methadone administration during treatment for neonatal abstinence syndrome: A feasibility study. Drug and Alcohol Dependence 2012;126:268-271.
Meyer M, Benvenuto A, Howard D, Johnston A, Plante D, Metayer J, Mandell T. J Addict Med. 2012 June:6(2): 124-30.
Meyer M, Mandell T, Johnston A, Smith D, Brooklyn J, Ustianov J, Metayer J, Davis W, Corbally J, Jones A, Tronsgard-Scott K, Sheehey M. Screening for Substance Abuse in Pregnancy. 2010. Vermont Child Health Improvement Project, University of Vermont. Also available on line at www.med.uvm.edu/vhip.
Johnston A, Mandell T, Meyer M. Treatment of Opioid Dependence in Pregnancy: Vermont Guidelines. 2010. Vermont Child Health Improvement Project, University of Vermont. Also available on line at www.med.uvm.edu/vchip.
Jones H, et al. Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure. N Engl J Med 2010;363:2320-31.
Johnston AM, Bullock CE, Graham JE, Reilly MC, Rocha C, Hoopes RD, Van Der Meid V, Gutierrez S, Abraham MR.; Implementation of Potentially Better Practices for Family-Centered Care: The Family-Centered Care Map; Pediatrics, 118: S108, 2006.
Dunn MS, Reilly MC, Johnston AM, Hoopes RD, Abraham MA. Development and Dissemination of Potentially Better Practices for the Provision of Family-Centered Care in Neonatology – the Family-Centered Care Map. Pediatrics 118: S95, 2006.
Anne Johnston. Neonatal Abstinence Syndrome. In Oski’s Pediatrics: Principles and Practice, Fourth Edition. Edited by McMillan, DeAngelis, Feigin and Warshaw, 2006.